Major weaknesses exist in the evidence base for COVID-19 antibody tests, finds a review of the latest research published by The BMJ today. The evidence is particularly weak for point-of-care tests (performed directly with a patient, outside of a laboratory) and ...
from Google Alert - health https://ift.tt/2NNVVhH
via IFTTT
0 comments:
Post a Comment